Authors: Isacson, O Costantini, L Schumacher, JM Cicchetti, F Chung, S Kim, SK

Citation: O. Isacson et al., Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cells, PARKINS R D, 7(3), 2001, pp. 205-212

Authors: Holm, KH Cicchetti, F Bjorklund, L Boonman, Z Tandon, P Costantini, LC Deacon, TW Huang, X Chen, DF Isacson, O

Citation: Kh. Holm et al., Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum, NEUROSCIENC, 104(2), 2001, pp. 397-405

Authors: Cicchetti, F Prensa, L Wu, Y Parent, A

Citation: F. Cicchetti et al., Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease, BRAIN RES R, 34(1-2), 2000, pp. 80-101

Authors: Freeman, TB Cicchetti, F Hauser, RA Deacon, TW Li, XJ Hersch, SM Nauert, GM Sanberg, PR Kordower, JH Saporta, S Isacson, O

Citation: Tb. Freeman et al., Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology, P NAS US, 97(25), 2000, pp. 13877-13882

Authors: Cicchetti, F Vinet, J Beach, TG Parent, A

Citation: F. Cicchetti et al., Differential expression of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits by calretinin-immunoreactive neurons in the human striatum, NEUROSCIENC, 93(1), 1999, pp. 89-97

Authors: O'Kusky, JR Nasir, J Cicchetti, F Parent, A Hayden, MR

Citation: Jr. O'Kusky et al., Neuronal degeneration in the basal ganglia and loss of pallido-subthalamicsynapses in mice with targeted disruption of the Huntington's disease gene, BRAIN RES, 818(2), 1999, pp. 468-479